Sofinnova Ventures »

Sagimet Biosciences Inc-a shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 167k 7.73

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Genmab A/S Sponsored Ads (GMAB)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Rapport Therapeutics (RAPP)
Seaport Therapeutics
Ultragenyx Pharmaceutical (RARE)
Arrivent Biopharma (AVBP)
Bioage Labs (BIOA)
Bristol Myers Squibb (BMY)
Supernus Pharmaceuticals (SUPN)
Rhythm Pharmaceuticals (RYTM)
Gilead Sciences (GILD)
United Therapeutics Corporation (UTHR)
Cogent Biosciences (COGT)

View all positions for Sofinnova Ventures

Top funds holding Sagimet Biosciences Inc-a

BlackRock
Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Caligan Partners
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management

View all funds holding Sagimet Biosciences Inc-a